Incyte Corp. sell BMO Capital Markets
Start price
15.06.26
/
50%
€88.84
Target price
15.06.27
-
Performance (%)
16.67%
Price
31.07.26
€103.65
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 16.67%. This prediction currently runs until 15.06.27. The prediction end date can be changed by BMO_Capital_Markets at any time. BMO_Capital_Markets has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Incyte Corp. | 0.145% | 0.145% |
| iShares Core DAX® | 2.591% | 2.691% |
| iShares Nasdaq 100 | -0.915% | -7.368% |
| iShares Nikkei 225® | 0.145% | -10.196% |
| iShares S&P 500 | -0.367% | -0.833% |
Comments by BMO_Capital_Markets for this prediction
In the thread Incyte Corp. diskutieren
Incyte (INCY) had its "underperform" rating reaffirmed by BMO Capital Markets.
Ratings data for INCY provided by MarketBeat